(19)
(11)EP 1 382 351 B8

(12)CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15)Correction information:
Corrected version no 1 (W1 B1)

(48)Corrigendum issued on:
08.03.2006 Bulletin 2006/10

(45)Mention of the grant of the patent:
23.11.2005 Bulletin 2005/47

(21)Application number: 03019610.9

(22)Date of filing:  03.03.2000
(51)International Patent Classification (IPC): 
A61K 45/06(1985.01)
A61P 9/00(2000.01)
A61K 31/585(1985.01)

(54)

Combination therapy of angiotensin converting enzyme inhibitor and epoxy-steroidal aldosterone antagonist for treatment of cardiovascular disease

Kombinationstherapie von Angiotensin-konvertierendem Enzymhemmer und Epoxy-steroidalem Aldosteron Antagonist zur Behandlung von kardiovaskulären Erkrankungen

Combinaison thérapeutique d'un inhibiteur d'enzyme de conversion de l'angiotensine et d'un antagoniste d'aldostérone epoxy-stéroidique pour le traitement des maladies cardiovasculaires


(84)Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
AL LT LV MK RO SI

(30)Priority: 05.03.1999 US 122977 P

(43)Date of publication of application:
21.01.2004 Bulletin 2004/04

(62)Application number of the earlier application in accordance with Art. 76 EPC:
00912174.0 / 1165136

(73)Proprietor: G.D. Searle LLC.
Chicago, Illinois 60680-5110 (US)

(72)Inventors:
  • Alexander, John C.
    Winnetka, Illinois 60093 (US)
  • Roniker, Barbara
    Chicago, Illinois 60610 (US)
  • Desai, Subhash
    Wilmette Illinois 60091 (US)

(74)Representative: Albrecht, Thomas et al
Kraus & Weisert, Thomas-Wimmer-Ring 15
80539 München
80539 München (DE)


(56)References cited: : 
WO-A-96/40255
WO-A-96/40257
  
      
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).